Growth-hormone axis

CJC-1295 (no DAC) + Ipamorelin

A combination identity in Aliquot's logging catalog. Aliquot does not infer a combined half-life or evidence profile from component records.

Canonical ID
cjc-1295-no-dac-ipamorelin
Evidence type
Editorially withheld combination record
Human PK
Not published

Overview

This intentionally sparse page avoids synthesizing unsupported conclusions from separate component records.

No combined human evidence summary has been approved for publication.

Human pharmacokinetic context

Not published

Aliquot has not published a route-matched human half-life statement for this entry.

Half-life is descriptive population context, not a dosing interval, a prediction of an individual's response, or a recommendation. Route-mismatched and uncited estimates are withheld.

Limitations

  • Component evidence cannot be added together to create a combination claim.
  • No combined half-life statement is published.

Related calculation tools

Aliquot's browser-only tools transform values you already have. They do not select a compound, suggest an amount, provide presets, or store your entries.

Sources

  1. Drugs@FDA: FDA-approved drugs Regulatory database · U.S. Food and Drug Administration · accessed 2026-07-28 Regulatory database consulted during review; no combination conclusion is asserted.
  2. Aliquot compound library methodology Editorial methodology · Aliquot · accessed 2026-07-28 Combination and withholding rules.

Aliquot Compound Library

Before you browse

Aliquot's Compound Library is an educational reference. Here is how to read and use it.

Educational, not medical advice

The library does not diagnose, treat, prevent, recommend a compound, or replace a licensed clinician. Consult a qualified clinician for personal health decisions.

Evidence has boundaries

Summaries draw from cited public regulator records, peer-reviewed human studies, PubMed records, and trial registrations. A citation does not make a claim conclusive.

No community health profiles

Aliquot does not collect community protocols or outcomes for this library. Calculator entries remain in your browser tab and are not submitted or saved.

Content and reuse

Aliquot's original editorial text and presentation may not be copied, scraped, mirrored, or redistributed without written permission. Linked sources remain subject to their publishers' terms.

Reviewed by Aliquot editorial review on 2026-07-28. Next scheduled review: 2026-10-26. Methodology and corrections.